Drug intelligence / Profile preview

VRP-1020

Development stage: Preclinical
Lead developer: Venus Medicine Research Centre
Administration: Transdermal

Overview

VRP-1020 is a natural extract currently in preclinical development by the Venus Medicine Research Centre (VMRC). It is part of a series of herbal and natural products in the company's pipeline, which includes other candidates such as VRP-1016, VRP-1023, and VRP-1024. While the specific active ingredients and therapeutic indications for VRP-1020 have not been publicly disclosed by the sponsor, the program has completed its formulation and development (F&D) phase. As of the latest pipeline reports, preclinical studies are ongoing, with clinical trials and regulatory filings pending.

Beyond the preview

Go deeper on VRP-1020.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VRP-1020.

Explore the full profile